All products / DC9862
Niraparib(MK4827) hydrochloride
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $500 USDRequest a quote → |
| 250 mg | $900 USDRequest a quote → |
| 1 g | $1,900 USDRequest a quote → |
In stock. Contact our team for lead time, shipping and final quotation.
Product overview
Niraparib hydrochloride (MK-4827 hydrochloride) is an excellent PARP1 and PARP2 inhibitor with IC50 of 3.8 and 2.1 nM, respectively.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC9862 |
|---|---|
| Product name | Niraparib(MK4827) hydrochloride |
| CAS | 1038915-64-8 |
| Molecular formula | C19H21ClN4O |
| Molecular weight | 356.854 |
| Purity | 99% |
| SMILES | NC(C1=CC=CC2=CN(C3=CC=C([C@H]4CNCCC4)C=C3)N=C21)=O.Cl |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — Niraparib(MK4827) hydrochloride (DC9862)Source references
[1]. Jones P, et al. Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors. J Med Chem. 2009 Nov 26;52(22):7170-85. [2]. Bridges KA, et al. Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells. Oncotarget. 2014 Jul 15;5(13):5076-86. [3]. Wang L, et al. MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation. Invest New Drugs. 2012 Dec;30(6):2113-20.
